Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML

This study has been completed.
Sponsor:
Collaborator:
Bayer
Information provided by:
University Hospital Muenster
ClinicalTrials.gov Identifier:
NCT00373373
First received: September 6, 2006
Last updated: August 18, 2009
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)